Prosigna Breast Cancer Prognostic Gene Signature Assay

PAM50-Based Prosigna Breast Cancer Assay Helps to Identify Patients at Risk of Late Distant Recurrence in a Combined Analysis of 2,137 Patients
Yahoo/BusinessWire
Sat, 12/14/13 - 11:50 am
Prosigna Breast Cancer Prognostic Gene Signature Assay
NanoString Technologies
breast cancer
NanoString says study demonstrates advantages of breast cancer assay
Yahoo/Fly on the Wall
Tue, 07/2/13 - 09:33 am
NanoString
breast cancer
Prosigna Breast Cancer Prognostic Gene Signature Assay